Not logged inInvestigating the effects and underlying mechanisms of glycosylation sites on the immunogenicity of COVID-19 vaccines
Wang, Heru; Li, Xiang; He, Peng; Yang, Sen; Liu, Xiaoya; Zhu, Qianhui; Liu, Pan; Fang, Xin; Wang, Chenfei; Bi, Ying; Jiang, Gaojian; Sun, Yufei; Chen, Hongxu; Gao, Tie; Luo, Ji; Rong, Huan; Liu, Xiaosa; Wang, Xiangxi; Zhang, Yuxia; Hu, Zhongyu .png)
Share.png)
SaveSafety, tolerability and immunogenicity of a quadrivalent recombinant norovirus vaccine (Pichia pastoris) in participants six weeks of age or older: Phase I/IIa trialChen, Gang; Shi, Liwei; Yu, Qingchuan; Liu, Qingwei; Wang, Xuanyi; Liu, Yan; Ding, Fan; Yuan, Lingfeng; Wang, Ping; Zhou, Xiang; Zhang, Yong; Huang, Zhong; Li, Jingjing; Hu, Zhongyu; Huang, Teng Share Save Share Save CVA16 infection causes neurological injury by engaging TLR2/MYD88/ TNF-α/CXCL1 signalling pathway in hSCARB2 knock-in miceWang, Yu; Wu, Yong; Wang, Yuya; Xiong, Rui; Ling, Chen; Cao, Yuan; Wang, Yining; Yang, Yanwei; Qu, Zhe; Xu, Nan; Liu, Susu; Li, Weijia; Lv, Zhe; Hu, Zhongyu; Fan, Changfa Share Save Safety and Immunogenicity of a New Rotavirus-Inactivated Vaccine in the Chinese Adolescent Population: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical TrialLiu, Yan; Feng, Guangwei; Wu, Jinyuan; Liu, Xinling; Pu, Jing; Wang, Yanxia; You, Wangyang; Yin, Na; Yi, Shan; Tan, Jiebing; Lin, Xiaochen; Huang, Lili; Gao, Jiamei; Yu, Qingchuan; Tong, Qiumeng; Zhang, Yong; Chen, Rong; Hu, Xiaoqing; Ye, Jun; Kuang, Xiangjing; Zhou, Yan; Hu, Zhongyu; Zhao, Dongyang; Li, Hongjun Share Save High-Precision Rayleigh Doppler Lidar with Fiber Solid-State Cascade Amplified High-Power Single-Frequency Laser for Wind MeasurementYang, Bin; Bu, Lingbing; Huang, Cong; Tan, Zhiqiang; Hu, Zhongyu; Shu, Shijiang; Deng, Chen; Li, Binbin; Ding, Jianyong; Yu, Guangli; Wang, Yungang; Wang, Cong; Lin, Weixia; Zong, Weiguo Share Save Sustained immunogenicity of bivalent protein COVID-19 vaccine SCTV01C against antigen matched and mismatched variantsWang, Guiqiang; Zhao, Kexin; Zhao, Xiuli; Cui, Yimin; He, Peng; Zhang, Tianzuo; Wang, Yanchao; Shi, Rui; Li, Yanhua; Wang, Qian; Ren, Yanping; Chen, Zhisong; Zhao, Xuedan; Xie, Zekang; Liang, Yufei; Tian, Qingyun; Pan, Jing; Zhang, Chao; Han, Ying; Dai, Yuyang; Ni, Siyang; Zhang, Yun; Yang, Xinjie; Fu, Yongpan; Liu, Dongfang; Li, Jing; Zhang, Miaomiao; Hu, Zhongyu; Xie, Liangzhi Share Save Share Save Safety, tolerability, and immunogenicity of a CpG/Alum adjuvanted SARS-CoV-2 recombinant protein vaccine (ZR202-CoV) in healthy adults: Preliminary report of a phase 1, randomized, double-blind, placebo-controlled, dose-escalation trialFeng, Guang-Wei; Wang, Zhong-Fang; He, Peng; Lan, Qin-Ying; Ni, Ling; Yang, Ya-Zheng; Wang, Chen-Fei; Cui, Ting-Ting; Huang, Li-Li; Yan, Yong-Qiang; Jiang, Zhi-Wei; Yang, Qing; Yu, Bang-Wei; Han, Xi; Chen, Jing-Jing; Yang, Shu-Yuan; Yuan, Lin; Zhou, Ling-Yun; Liu, Ge; Li, Ke; Huang, Zhen; Zhao, Jin-Cun; Hu, Zhong-Yu; Xie, Zhi-Qiang Share Save Share Save Safety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3-17years in China: a randomised, double-blind, placebo- controlled, phase 1trial and an open-label, non-randomised, non-inferiority, phase 2 trialGao, Lidong; Li, Yan; He, Peng; Chen, Zhen; Yang, Huaiyu; Li, Fangjun; Zhang, Siyuan; Wang, Danni; Wang, Guangyan; Yang, Shilong; Gong, Lihui; Ding, Fan; Ling, Mengyu; Wang, Xilu; Ci, Leilei; Dai, Lianpan; Gao, George Fu; Huang, Tao; Hu, Zhongyu; Ying, Zhifang; Sun, Jiufeng; Zuo, Xiaohu Share Save Safety and immunogenicity of a bivalent SARS-CoV-2 recombinant protein vaccine, SCTV01C in unvaccinated adults: A randomized, double-blinded, placebo-controlled, phase I clinical trialWang, Guiqiang; Zhao, Kexin; Han, Jun; Hu, Zhongyu; Zhang, Tianzuo; Wang, Yanchao; Shi, Rui; Li, Yanhua; Song, Qinqin; Du, Haijun; He, Peng; Xu, Shuping; Yang, Xinjie; Fu, Yongpan; Cui, Yimin; Xie, Liangzhi Share Save The immunodominance of RBD antigen of delta variant as vaccine candidate against SARS-CoV-2 infectionLuo, Deyan; Li, Tao; Yang, Xiaolan; Ning, Nianzhi; Zhang, Liangyan; Gu, Hongjing; Li, Deyu; Yu, Wenjing; Hu, Zhongyu; Wang, Hui Share Save A potent, broadly protective vaccine against SARS-CoV-2 variants of concernWang, Ziyan; An, Jiao; Liu, Kunpeng; Yu, Pin; Fang, Xin; Li, Jiadai; Zhu, Hua; Zhu, Qianjun; Huang, Chuanqi; Zhang, Chao; Zhao, Binbin; Bao, Linlin; Song, Yujiao; Cao, Xiayao; Hu, Dongdong; Jiang, Yuanxiang; Shi, Likang; Zhou, Lingyun; Fan, Jiang; Guan, Wuxiang; Zhou, Chenliang; Hu, Zhongyu; Yuan, Zhiming; Liu, Jiangning; Shan, Chao; Liu, Ge Share Save A randomized, double-blind, placebo-controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS-CoV-2 vaccine SCoK in adultsLuo, Deyan; Pan, Hongxing; He, Peng; Yang, Xiaolan; Li, Tao; Ning, Nianzhi; Fang, Xin; Yu, Wenjing; Wei, Mingwei; Gao, Hui; Wang, Xin; Gu, Hongjing; Mei, Maodong; Li, Xinwang; Zhang, Liangyan; Li, Deyu; Gao, Chunrun; Gao, Jinbang; Fei, Guoqiang; Li, Ying; Yang, Yuguo; Xu, Yi; Wei, Wenjin; Sun, Yansong; Zhu, Fengcai; Hu, Zhongyu; Wang, Hui Share Save Immunogenicity and safety of a recombinant fusion protein vaccine (V-01) against coronavirus disease 2019 in healthy adults: a randomized, double-blind, placebo-controlled, phase II trialShu, Ya-Jun; He, Jian-Feng; Pei, Rong-Juan; He, Peng; Huang, Zhu-Hang; Chen, Shao-Min; Ou, Zhi-Qiang; Deng, Jing-Long; Zeng, Pei-Yu; Zhou, Jian; Min, Yuan-Qin; Deng, Fei; Peng, Hua; Zhang, Zheng; Wang, Bo; Xu, Zhong-Hui; Guan, Wu-Xiang; Hu, Zhong-Yu; Zhang, Ji-Kai Share Save Safety and immunogenicity of a recombinant interferon-armed RBD dimer vaccine (V-01) for COVID-19 in healthy adults: a randomized, double-blind, placebo-controlled, Phase I trialLiao, Yuyi; Li, Yuan; Pei, Rongjuan; Fang, Xin; Zeng, Peiyu; Fan, Renfeng; Ou, Zhiqiang; Deng, Jinglong; Zhou, Jian; Guan, Wuxiang; Min, Yuanqin; Deng, Fei; Peng, Hua; Zhang, Zheng; Feng, Chunyan; Xin, Baobao; He, Jianfeng; Hu, Zhongyu; Zhang, Jikai Share Save Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trialsYang, Shilong; Li, Yan; Dai, Lianpan; Wang, Jianfeng; He, Peng; Li, Changgui; Fang, Xin; Wang, Chenfei; Zhao, Xiang; Huang, Enqi; Wu, Changwei; Zhong, Zaixin; Wang, Fengze; Duan, Xiaomin; Tian, Siyu; Wu, Lili; Liu, Yan; Luo, Yi; Chen, Zhihai; Li, Fangjun; Li, Junhua; Yu, Xian; Ren, Hong; Liu, Lihong; Meng, Shufang; Yan, Jinghua; Hu, Zhongyu; Gao, Lidong; Gao, George F. Share Save Significant transcriptome and cytokine changes in hepatitis B vaccine non-responders revealed by genome-wide comparative analysisQiu, Shaohui; He, Peng; Fang, Xin; Tong, Haiqing; Lv, Jingjing; Liu, Jiaye; Zhang, Li; Zhai, Xiangjun; Wang, Liying; Hu, Zhongyu; Yu, Yongli Share Save Analysis of immunological mechanisms exerted by HBsAg-HBIG therapeutic vaccine combined with Adefovir in chronic hepatitis B patientsZhou, Chenliang; Li, Chaofan; Gong, Guo-Zhong; Wang, Shuang; Zhang, Ji-Ming; Xu, Dao-Zhen; Guo, Li-Min; Ren, Hong; Xu, Min; Xie, Qing; Pan, Chen; Xu, Jie; Hu, Zhongyu; Geng, Shuang; Zhou, Xian; Wang, Xianzheng; Zhou, Xiaoyu; Mi, Haili; Zhao, Gan; Yu, Wencong; Wen, Yu-Mei; Huang, Lihua; Wang, Xuan-Yi; Wang, Bin Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
